Trial intelligence / Profile preview

Multimodal Pain Package vs. Bottled Formulation in Spinal Surgery

NCT05965492Phase 3Withdrawn

Sponsor
University of Miami
Start
Jun 2024
Primary completion
Jun 2025
01

Overview

Phase 3, randomised, open-label trial (2 arms), sponsored by University of Miami. Primary endpoints: Adherence measured by the self-report medication nonadherence scale at 7 days, Satisfaction measured by Satisfaction Likert Scale at 7 days and 1 more. Planned start Jun 2024; status: withdrawn.

Beyond the preview

Go deeper on NCT05965492.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05965492.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call